Research Solutions, Inc. (NASDAQ:RSSS) Q2 2024 Earnings Conference Call February 8, 2024 5:00 PM ET Company Participants John Beisler - Three Part Advisors, Investor Relations Roy Olivier - President & Chief Executive Officer William Nurthen - Chief Financial Officer Conference Call Participants Allen Klee - Maxim Group Operator Good day and welcome to the Research Solutions, Inc. Second Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now lik ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File No. 001-39256 RESEARCH SOLUTIONS, INC. (Exact name of registrant as specified in its charte ...

Research Solutions, Inc. (NASDAQ:RSSS) Q1 2024 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants John Beisler - Three Part Advisors, Investor Relations Roy Olivier - Chief Executive Officer and President William Nurthen - Chief Financial Officer Conference Call Participants Richard Baldry - ROTH Capital Allen Klee - Maxim Group Operator Thank you for standing by. This is the conference operator. Welcome to the Research Solutions Inc. First Quarter 2024 Earnings Conference Call. As a ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File No. 001-39256 RESEARCH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) Nevada 11- ...

财务数据和关键指标变化 - 2023财年全年收入增长14.5%至37.7百万美元,为公司10多年来首次实现两位数增长 [17] - 平台订阅收入全年增长28%至8.7百万美元 [17] - 年度经常性收入(ARR)为9.4百万美元,较上年增长19% [12] - 毛利率为39%,较上年提升250个基点 [21] - 实现GAAP净利润573,000美元,为2015年以来首次实现盈利 [23] - 调整后EBITDA达200万美元,创历史新高 [23] - 经营活动产生现金流3.4百万美元,也创历史新高 [24] 各条业务线数据和关键指标变化 - 平台业务毛利率为88.2%,较上年提升200个基点 [21] - 交易业务毛利率为24.3%,较上年提升70个基点 [21] - 平台部署总数达835个,较上年净增102个,增长14% [17][18] - 交易收入增长11%至29百万美元,主要来自有机增长 [19][20] 各个市场数据和关键指标变化 - 客户总数增加191家至1,404家,主要来自FIZ交易客户的并购 [13] - 学术图书馆市场取得Royal Danish Library客户,体现了Article Galaxy Scholar解决方案的成功 [31] - B2C业务方面,每月有约20,000名用户访问平台,并正在努力将其转化为付费用户 [32] 公司战略和发展方向及行业竞争 - 完成FIZ客户并购,增加300家客户,并有200家客户在过去6个月内购买文献 [29][30] - 收购ResoluteAI,将增加公司的AI技术和搜索能力,扩大总地址市场 [38][39] - 正在洽谈两项额外收购,预计将带来约4百万美元的经常性收入 [39] - 持续投资于销售和营销,以期在经济复苏时抓住机遇 [34][35][36][37] 管理层对经营环境和未来前景的评论 - 尽管面临一些短期挑战,但对未来前景保持乐观 [40] - 认为目前的一些独特事项(代理费用、并购等)将对短期业绩产生影响,但不会改变核心业务的盈利能力和现金流特征 [26][27] 其他重要信息 - 公司实施了OKR框架,确保全公司上下围绕执行计划保持一致 [37] - 在产品方面持续推出新功能,包括PICO标签识别、AI推荐引擎和ChatGPT等 [33] - 在营销方面取得多项进展,如网站访问量翻倍、B2C交易收入翻倍等 [35] 问答环节重要的提问和回答 问题1 **Richard Baldry 提问** 对于Q1季节性收入变化,考虑到并购影响和宏观环境,公司如何看待? [43] **Bill Nurthen 回答** 预计Q1交易收入增长仍将保持两位数,但增速会低于Q3和Q4;ResoluteAI产品销售在Q1不会有太大影响 [45][46] 问题2 **Allen Klee 提问** ResoluteAI收购对公司业绩的影响如何,以及收购条款中的earn-out机制是什么? [54] **Bill Nurthen 回答** ResoluteAI短期内将对业绩产生一定拖累,但公司正采取措施改善其经营;earn-out机制是基于其18个月后的ARR水平计算 [55][56] 问题3 **Peter Rabover 提问** 对于公司当前的代理权之争,他认为这是一件令人尴尬的事情,建议尽快解决 [66] **Roy W. Olivier 回答** 对于代理权之争,公司目前没有新的进展可报告,管理层和独立董事会成员仍在继续推进公司战略 [40]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File No. 001-39256 RESEARCH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) N ...

Research Solutions, Inc. (NASDAQ:RSSS) Q3 2023 Earnings Conference Call May 11, 2023 5:00 PM ET Company Participants John Beisler – Investor Relations Roy W. Olivier – President and Chief Executive Officer Bill Nurthen – Chief Financial Officer Conference Call Participants Allen Klee – Maxim Operator Good afternoon everyone and thank you for participating in today’s conference call to discuss Research Solutions’ Financial and Operating Results for its Fiscal Third Year Ended March 31, 2023. As a reminder, t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File No. 001-39256 RESEARCH SOLUTIONS, INC. (Exact name of registrant as specified in its charter ...

Research Solutions, Inc. (NASDAQ:RSSS) Q2 2023 Earnings Conference Call February 9, 2023 5:00 PM ET Company Participants John Beisler - Investor Relations Roy Olivier - President & Chief Executive Officer William Nurthen - Chief Financial Officer Conference Call Participants Richard Baldry - ROTH Capital Allen Klee - Maxim Group Peter Rabover - Artko Capital George Melas - MKH Management Operator Thank you for standing by. This is the conference operator. Welcome to the Research Solutions' Second Quarter 20 ...